Literature DB >> 2905622

Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine.

O Curet1, C de Montigny.   

Abstract

The rat hippocampus receives a dense noradrenergic innervation originating exclusively from the locus coeruleus. The present electrophysiological study was undertaken to characterize the adrenoceptor mediating the suppressant effect of microiontophoretically applied norepinephrine (NE) on CA1 and CA3 dorsal hippocampus pyramidal neurons of the rat. The rank order of potency of microiontophoretically applied agonists, in suppressing the firing rate of hippocampus pyramidal neurons was: oxymetazoline greater than NE greater than phenylephrine greater than isoproterenol greater than clonidine. In the hippocampus, oxymetazoline was more potent than NE, whereas it was ineffective in the lateral geniculate nucleus where the effect of NE is mediated by an alpha 1-adrenoceptor. Low currents of clonidine antagonized the effect of NE suggesting that clonidine may exert a partial agonistic effect. The rank order of potency of i.v. administered adrenergic antagonists in blocking the suppressant effect of microiontophoretically applied NE was: idazoxan much greater than prazosin much greater than propranolol. Idazoxan also blocked the effect of oxymetazoline, phenylephrine, and isoproterenol but did not modify the effect of microiontophoretically applied gamma-aminobutyric acid (GABA). In addition, idazoxan, applied by microiontophoresis, readily blocked the suppressant effect of NE without affecting that of GABA. These results suggest that the suppressant effect of microiontophoretically applied NE on rat dorsal hippocampus pyramidal neurons is primarily mediated by alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905622     DOI: 10.1016/0006-8993(88)90196-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli.

Authors:  P Szot; D Weinshenker; S S White; C A Robbins; N C Rust; P A Schwartzkroin; R D Palmiter
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Noradrenergic modulation of basolateral amygdala neuronal activity: opposing influences of alpha-2 and beta receptor activation.

Authors:  Deanne M Buffalari; Anthony A Grace
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

3.  Activation and inhibition of neurons in the hippocampal ventral subiculum by norepinephrine and locus coeruleus stimulation.

Authors:  Witold J Lipski; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

4.  Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion.

Authors:  Ramez Ghanbari; Mostafa El Mansari; Pierre Blier
Journal:  Psychopharmacology (Berl)       Date:  2011-03-29       Impact factor: 4.530

5.  Modulatory effects of acetylcholine, serotonin and noradrenaline on the activity of cat perigeniculate neurons.

Authors:  K Funke; U T Eysel
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

6.  Functional characterization of neuronal pre and postsynaptic alpha 2-adrenoceptor subtypes in guinea-pig submucosal plexus.

Authors:  K Z Shen; C Barajas-Lopez; A Surprenant
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

7.  Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia.

Authors:  Stephanie M Perez; Flavia R Carreno; Alan Frazer; Daniel J Lodge
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

8.  Noradrenergic modulation of retinogeniculate transmission in the cat.

Authors:  K Funke; H C Pape; U T Eysel
Journal:  J Physiol       Date:  1993-04       Impact factor: 5.182

9.  β-Adrenoceptor activation depresses brain inflammation and is neuroprotective in lipopolysaccharide-induced sensitization to oxygen-glucose deprivation in organotypic hippocampal slices.

Authors:  Tina Markus; Stefan R Hansson; Tobias Cronberg; Corrado Cilio; Tadeusz Wieloch; David Ley
Journal:  J Neuroinflammation       Date:  2010-12-20       Impact factor: 8.322

10.  Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study.

Authors:  Chris A Oosterhof; Mostafa El Mansari; Christoffer Bundgaard; Pierre Blier
Journal:  Int J Neuropsychopharmacol       Date:  2015-10-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.